Form 4 holding
Chief Financial Officer
Immunovant, Inc.
- Security class
- Common Stock
- Shares / value
- 396,774
- Estimated value
- $5,907,965
- Report date
- 16 Apr 2025
- Price
- $14.89
- Ownership
- Direct
Eva Renee Barnett - Chief Financial Officer at Immunovant, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- IMVT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Eva Renee Barnett since 10 Sep 2025
Reported holdings for Eva Renee Barnett in Immunovant, Inc.
Form 4 holding
Chief Financial Officer
Immunovant, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 125,180
- Estimated value
- Report date
- 01 Apr 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Eva Renee Barnett in Immunovant, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.